Aspergillus Terreus
Voriconazole may be better than a polyene for Aspergillus terreus infection
Published in Anti-Infectives Week, September 20th, 2004
According to recent research published in the journal Clinical Infectious Diseases, "Current in vitro and in vivo data indicate that invasive aspergillosis due to Aspergillus terreus is resistant to treatment with amphotericin B.
"Because little clinical data are available to guide therapy, we performed a retrospective cohort study of cases of invasive A. terreus infections from 1997-2002 to determine whether the use of voriconazole, compared with use of other antifungal therapies, led to an improved patient outcome."
"We...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
Source: Anti-Infectives Week (2004-09-20)
More Articles from Anti-Infectives Week
- Anti-Infectives
Effect of magnesium glutamate on aqueous penicillin G stability determined - Anti-Infectives
Quality control guidelines for investigational cephalosporin presented - Bacterial Infection
Age/primary infection foci differs in invasive/noninvasive group A streptococci - Hemorrhagic Fever
Ribavarin therapy effective against Crimean-Congo hemorrhagic fever - Antiretroviral Therapy
HAART improves course of hepatitis C virus infection in HIV coinfected patients - Antiretroviral Therapy
Novel bioelectronic method detects HIV-1 drug resistance - More from this issue of Anti-Infectives Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
